Shares

62 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$41.99 - $62.38 $6,676 - $9,918
159 Added 17.57%
1,064 $62,000
Q3 2023

May 09, 2024

SELL
$27.8 - $45.35 $528 - $861
-19 Reduced 2.06%
905 $39,000
Q3 2023

Apr 29, 2024

BUY
$27.8 - $45.35 $55 - $90
2 Added 0.22%
905 $39,000
Q3 2023

Nov 14, 2023

BUY
$27.8 - $45.35 $55 - $90
2 Added 0.22%
905 $39,000
Q2 2023

Apr 29, 2024

BUY
$36.13 - $49.49 $32,625 - $44,689
903 New
903 $32,000
Q2 2023

Aug 10, 2023

SELL
$36.13 - $49.49 $758 - $1,039
-21 Reduced 2.27%
903 $32,000
Q1 2023

May 09, 2024

BUY
$36.54 - $54.26 $33,762 - $50,136
924 New
924 $34.4 Million
Q1 2023

May 15, 2023

BUY
$36.54 - $54.26 $73 - $108
2 Added 0.22%
924 $34,000
Q4 2022

May 10, 2024

BUY
$41.27 - $98.62 $1,526 - $3,648
37 Added 4.18%
922 $41,000
Q4 2022

Jun 14, 2023

SELL
$41.27 - $98.62 $82 - $197
-2 Reduced 0.22%
922 $41,000
Q4 2022

Mar 22, 2023

BUY
$41.27 - $98.62 $1,526 - $3,648
37 Added 4.18%
922 $41,000
Q4 2022

Feb 15, 2023

BUY
$41.27 - $98.62 $1,526 - $3,648
37 Added 4.18%
922 $41,000
Q3 2022

May 10, 2024

SELL
$59.5 - $86.7 $1,249 - $1,820
-21 Reduced 2.32%
885 $61,000
Q3 2022

Jun 14, 2023

SELL
$59.5 - $86.7 $2,320 - $3,381
-39 Reduced 4.22%
885 $61,000
Q3 2022

Mar 22, 2023

SELL
$59.5 - $86.7 $1,249 - $1,820
-21 Reduced 2.32%
885 $61,000
Q3 2022

Nov 14, 2022

SELL
$59.5 - $86.7 $1,249 - $1,820
-21 Reduced 2.32%
885 $62,000
Q2 2022

May 10, 2024

SELL
$39.16 - $88.71 $58,387 - $132,266
-1,491 Reduced 62.2%
906 $60,000
Q2 2022

Jun 20, 2023

SELL
$39.16 - $88.71 $704 - $1,596
-18 Reduced 1.95%
906 $60,000
Q2 2022

Mar 22, 2023

SELL
$39.16 - $88.71 $58,387 - $132,266
-1,491 Reduced 62.2%
906 $60,000
Q2 2022

Aug 11, 2022

SELL
$39.16 - $88.71 $58,387 - $132,266
-1,491 Reduced 62.2%
906 $61,000
Q1 2022

May 10, 2024

BUY
$75.82 - $150.97 $181,740 - $361,875
2,397 New
2,397 $197,000
Q1 2022

Jun 20, 2023

BUY
$75.82 - $150.97 $111,682 - $222,378
1,473 Added 159.42%
2,397 $197,000
Q1 2022

Mar 22, 2023

BUY
$75.82 - $150.97 $171,883 - $342,248
2,267 Added 1743.85%
2,397 $197,000
Q1 2022

May 12, 2022

BUY
$75.82 - $150.97 $181,740 - $361,875
2,397 New
2,397 $197,000
Q4 2021

Feb 15, 2022

SELL
$132.01 - $190.29 $17,161 - $24,737
-130 Closed
0 $0
Q3 2021

Mar 22, 2023

SELL
$132.13 - $177.45 $2.09 Million - $2.81 Million
-15,833 Reduced 99.19%
130 $22,000
Q3 2021

Nov 15, 2021

BUY
$132.13 - $177.45 $17,176 - $23,068
130 New
130 $23,000
Q2 2021

Aug 16, 2021

SELL
$144.0 - $179.73 $2.3 Million - $2.87 Million
-15,963 Closed
0 $0
Q1 2021

May 17, 2024

BUY
$158.92 - $221.61 $2.54 Million - $3.54 Million
15,963 New
15,963 $2.73 Million
Q1 2021

Jun 26, 2023

BUY
$158.92 - $221.61 $2.39 Million - $3.33 Million
15,039 Added 1627.6%
15,963 $2.73 Billion
Q1 2021

Mar 22, 2023

SELL
$158.92 - $221.61 $166,548 - $232,247
-1,048 Reduced 6.16%
15,963 $2.73 Million
Q1 2021

May 14, 2021

SELL
$158.92 - $221.61 $166,548 - $232,247
-1,048 Reduced 6.16%
15,963 $2.73 Million
Q4 2020

May 24, 2024

BUY
$162.05 - $240.27 $223,466 - $331,332
1,379 Added 8.82%
17,011 $3.74 Million
Q4 2020

Jun 22, 2023

BUY
$162.05 - $240.27 $2.61 Million - $3.87 Million
16,087 Added 1741.02%
17,011 $3.74 Million
Q4 2020

Mar 22, 2023

BUY
$162.05 - $240.27 $223,466 - $331,332
1,379 Added 8.82%
17,011 $3.74 Million
Q4 2020

Feb 16, 2021

BUY
$162.05 - $240.27 $223,466 - $331,332
1,379 Added 8.82%
17,011 $3.74 Million
Q3 2020

May 24, 2024

SELL
$113.26 - $167.27 $61,613 - $90,994
-544 Reduced 3.36%
15,632 $2.6 Billion
Q3 2020

Jun 26, 2023

BUY
$113.26 - $167.27 $1.67 Million - $2.46 Million
14,708 Added 1591.77%
15,632 $2.6 Million
Q3 2020

Mar 22, 2023

SELL
$113.26 - $167.27 $61,613 - $90,994
-544 Reduced 3.36%
15,632 $2.6 Million
Q3 2020

Nov 13, 2020

SELL
$113.26 - $167.27 $61,613 - $90,994
-544 Reduced 3.36%
15,632 $2.6 Million
Q2 2020

May 24, 2024

BUY
$72.01 - $120.39 $1.16 Million - $1.95 Million
16,176 New
16,176 $1.85 Billion
Q2 2020

Jun 26, 2023

BUY
$72.01 - $120.39 $1.1 Million - $1.84 Million
15,252 Added 1650.65%
16,176 $1.85 Million
Q2 2020

Mar 22, 2023

BUY
$72.01 - $120.39 $253,547 - $423,893
3,521 Added 27.82%
16,176 $1.85 Million
Q2 2020

Aug 14, 2020

BUY
$72.01 - $120.39 $253,547 - $423,893
3,521 Added 27.82%
16,176 $1.85 Million
Q1 2020

Jul 12, 2023

BUY
$69.78 - $116.21 $818,589 - $1.36 Million
11,731 Added 1269.59%
12,655 $972,000
Q1 2020

Mar 22, 2023

BUY
$69.78 - $116.21 $46,403 - $77,279
665 Added 5.55%
12,655 $972,000
Q1 2020

May 15, 2020

BUY
$69.78 - $116.21 $46,403 - $77,279
665 Added 5.55%
12,655 $973,000
Q4 2019

Jul 12, 2023

BUY
$70.76 - $128.86 $783,030 - $1.43 Million
11,066 Added 1197.62%
11,990 $1.55 Million
Q3 2019

Jul 12, 2023

BUY
$77.91 - $109.6 $862,152 - $1.21 Million
11,066 Added 1197.62%
11,990 $934,000
Q3 2019

Mar 22, 2023

BUY
$77.91 - $109.6 $187,996 - $264,464
2,413 Added 25.2%
11,990 $934,000
Q3 2019

Nov 14, 2019

BUY
$77.91 - $109.6 $187,996 - $264,464
2,413 Added 25.2%
11,990 $934,000
Q2 2019

Jul 12, 2023

BUY
$59.49 - $104.71 $613,639 - $1.08 Million
10,315 Added 1116.34%
11,239 $1.16 Million
Q1 2019

Jul 13, 2023

BUY
$43.65 - $78.95 $377,703 - $683,154
8,653 Added 936.47%
9,577 $701,000
Q1 2019

Mar 22, 2023

BUY
$43.65 - $78.95 $42,907 - $77,607
983 Added 11.44%
9,577 $701,000
Q1 2019

May 15, 2019

BUY
$43.65 - $78.95 $42,907 - $77,607
983 Added 11.44%
9,577 $702,000
Q4 2018

Jul 13, 2023

BUY
$32.0 - $47.43 $245,440 - $363,788
7,670 Added 830.09%
8,594 $364,000
Q4 2018

Mar 22, 2023

SELL
$32.0 - $47.43 $151,680 - $224,818
-4,740 Reduced 35.55%
8,594 $364,000
Q4 2018

Feb 14, 2019

SELL
$32.0 - $47.43 $151,680 - $224,818
-4,740 Reduced 35.55%
8,594 $365,000
Q3 2018

Jul 13, 2023

BUY
$47.1 - $62.7 $361,257 - $480,909
7,670 Added 830.09%
8,594 $404,000
Q3 2018

Mar 22, 2023

BUY
$47.1 - $62.7 $584,605 - $778,232
12,412 Added 1346.2%
13,334 $628,000
Q3 2018

Nov 14, 2018

BUY
$47.1 - $62.7 $223,254 - $297,198
4,740 Added 55.15%
13,334 $628,000
Q2 2018

Aug 15, 2018

BUY
$26.05 - $52.4 $223,873 - $450,325
8,594 New
8,594 $424,000

Others Institutions Holding MRTX

About Mirati Therapeutics, Inc.


  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.